Therefore, it appears that the capacity to readily repress PI3K/AKT-mediated GILZ expression disrupts the negative feedback on FOXO3A; this activity underlies a dormant cell-specific mechanism for controlling the quiescence/activation of murine MeSCs and the closely associated processes of tumour dormancy/relapse. The gene discussed is AKT1; the disease is neoplasm.